COLLABORATION AND DEVELOPMENT AgreementCollaboration Agreement • July 10th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
Contract Type FiledJuly 10th, 2018 Company Industry JurisdictionThis Collaboration Agreement (“Agreement”) is made as of July 5, 2018 (the “Effective Date”) by and between Ampersand Biopharmaceuticals, Inc, a Delaware corporation with offices located at 2545 W. Hillcrest Dr., Thousand Oaks, CA 91320 (“Ampersand”), and Zander Therapeutics, Inc. a Nevada corporation, with offices located at 4700 Spring Street, Suite 304 La Mesa, CA, 91942, USA (“Zander”). Ampersand and Zander are sometimes referred to in this Agreement individually as a “Party”, and collectively as the “Parties”.
SUBLEASE AGREEMENTSublease Agreement • July 10th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledJuly 10th, 2018 Company IndustryThis is an agreement to sublet office space located at 4700 Spring Street, Suite 304, La Mesa, California 91942 according to the terms specified below.